Evaluation of incidence of metabolic abnormalities in schizophrenic patients treating with olanzapine and sitagliptin in comparison with olanzapine and placebo
Latest Information Update: 30 Jul 2020
At a glance
- Drugs Olanzapine (Primary) ; Sitagliptin (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 30 Jul 2020 New trial record
- 12 Jul 2020 Results published in the Journal of Clinical Psychopharmacology